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Objective. To investigate the therapeutic eﬀects and mechanism of Salvia miltiorrhizae in the treatment of SAP and OJ. Methods.A
total of 288 rats were used for SAP- and OJ-associated experiments. The rats were randomly divided into sham-operated group,
model control group and treated group. The mortality rates of rats, contents of endotoxin and PLA2 in blood, patholodgical
changes of diﬀerent indexes in spleen and thymus were observed. Results. The contents of endotoxin and PLA2 in treated group
were signiﬁcantly lower than those in model control group.The pathological severity scores of spleen and thymus of SAP rats as
wellasthatofspleenofOJratsintreatedgroupsweresigniﬁcantlylowerthanthoseinmodelcontrolgroups(P<. 05).Thestaining
intensity as well as the product of the staining intensity and positive rate of Bax protein of spleen in model control group were
signiﬁcantly higher than those in treated groups (P<. 01) , and the apoptosis index of spleen in treated group was signiﬁcantly
lower than that in model control group (P<. 01). Conclusion. Salvia miltiorrhizae exerts protective eﬀects on the spleen and
thymus of SAP rats and spleen of OJ rats.
Copyright © 2009 Zhang Xiping et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Since severe acute pancreatitis (SAP) and obstructive jaun-
dice (OJ) are common diseases, the study of their patho-
genesis and treatment has been a hot spot in medical ﬁeld
for a long time [1–4]. Severe acute pancreatitis (SAP) is a
systemic disease resulted from pancreatic self-digestion and
characterized by pancreatic necrosis. It can induce vascular
leakage, shock, systemic inﬂammatory response syndrome
(SIRS), and even multiple organ dysfunction (MODS) [5, 6].
Although SAP is dangerous, has many complications, and
shows a higher mortality rate, the mechanism underlying
this disease has not yet been fully clariﬁed [7–9]. As the
study of SIRS and MODS is deepened, the immune function
injury in SAP has gradually attracted more attention. Some
studies have shown that both pancreatic and extrapancreatic
manifestations of SAP are closely related with immune
function [10]. Also, the observation that low immune
function is an important contributing factor for the death
of OJ patients should not be ignored. Therefore, one of
the most important approaches for treating SAP and OJ
is to improve the function of the patient’s immune system
[11–14]. At present, the drugs that show speciﬁc eﬀects on
injuries of immune organs in SAP or OJ are lacking, and few
studies have been found to investigate this kind of drugs. The
development and utilization of traditional Chinese medicine
showgoodprospectsinthetherapyofSAPandOJsinceithas
advantages of lower cost, more extensive pharmacological
eﬀe c t s ,a n dl e s ss i d ee ﬀects [15–18].
Salvia miltiorrhizae injection belongs to a traditional
Chinese medicine injection that can improve microcircula-
tion, scavenge oxygen free radicals, regulate the metabolism
of inﬂammatory lipid mediators, protect intestinal mucosa,
and decrease the levels of inﬂammatory mediators [19, 20].
Some scholars believe that Salvia miltiorrhizae also can
enhance macrophage function, inhibit platelet aggregation,
reduce blood viscosity, prevent microvascular coagulation,
and relieve vascular spasm and occlusion [21]. Some clinical
studies have shown that Salvia miltiorrhizae, as an auxiliary
drug, have some therapeutic eﬀects on SAP and OJ. Salvia2 Mediators of Inﬂammation
miltiorrhizae is able to improve the clinical symptoms and
signiﬁcantly shorten the recovery duration of hematuria
amylase levels and liver function damage, the remission
duration of abdominal pain, as well as the duration of
hospitalization in patients with SAP [22]. Moreover, Salvia
miltiorrhizae can also protect intestinal mucosa, reduce the
translocationofbacteriaandendotoxins,enhanceimmunity,
improve operative safety, and shorten healing duration in
patients with OJ [23].
In the present study, we have applied tissue microarray
technology to examine the pathological changes in the
spleen and thymus of SAP and OJ rats, and investigated the
protective eﬀect of Salvia miltiorrhizae on the spleen and
thymus of SAP and OJ rats and the associated mechanism.
We hope this research can provide some valued materials for
clinical application of Salvia miltiorrhizae.
2.MaterialsandMethods
2.1. Materials. A total of 288 healthy male SD rats of clean
grade, weighing between 270 and 330g, were provided by
the Laboratory Animal Research Center of the Zhejiang
University of Traditional Chinese Medicine (China); Sodium
taurocholateandsodiumpentobarbitalwerepurchasedfrom
Sigma Corporation, USA; Salvia miltiorrhizae injection (also
called Danshen injection, each 10mL vial contains active
components equivalent to 15g of the original medicine) was
purchased from Chiatai Qingchunbao Pharmaceutical Co.,
Ltd (China); Rabbit anti-mouse Bax antibody was purchased
from Santa Cruz Biotechnology, Inc. (USA); TUNEL assay
kit was purchased from Takara Bio Inc. (Japan). Endotoxin
ELISA Kit was purchased from Associates of Cape Cord
(USA), the calculation unit for content is EU/mL; The serum
secretory phospholipase A2 enzyme Assay ELISA kit (PLA2)
was purchased from R&D system Inc. (USA), the calculation
unit for content is U/mL.
2.2. Methods
2.2.1. Animal Grouping. A total of 108 rats were used
for SAP-associated experiments and randomly divided into
sham-operated group, model control group, and treated
group (n = 36), which were further randomly subdivided
into 3, 6, and 12 hours groups (n = 12) according to time
points after operation. Another 180 rats were utilized for
OJ-associatedexperimentsandrandomlydividedintosham-
operated group, model control group, and treated group
(n = 60), which were further randomly subdivided into
7, 14, 21, and 28d groups (n = 15) according to time
duration after operation. SAP was an acute experiment.
When the observering procedure time exceed 12 hours,
the mortality rate will increase largely, resulting in sample
numbers decrease largely and disadvantage to statistics.
According to references exterior and interior of our contury,
the 3, 6, 12 hour point was the most reasonable. However, OJ
was a chronic experiment, according to refereences exterior
and interior of our contury, the 7-, 14-, 21-, 28-day point
was the most reasonable.
2.2.2. Preparation of SAP Models and Associated Ther-
apeutic Regimens. The rats were anesthetized with an
intraperitoneal injection of 2.5% sodium pentobarbital
(0.2mL/100g). Under aseptic conditions, the thigh skin
w a sc u to p e nt oe x p o s ef e m o r a lv e i na n dat r a n s f u s i o n
passage was established through which continuous infusion
wasmaintainedusingamicroinfusionpump(1mL/h/100g).
Subsequently, a median abdominal wall incision was made
to expose duodenal papilla, and a number 5 syringe needle
was used to prick a small hole in the mesenteric avascular
area. The epidural catheter was ﬁrst inserted into duodenal
cavity via the hole, and then placed into the bile-pancreatic
duct toward the direction of papilla. The catheter head
was temporarily clamped using a microvascular clamp, and
another microvascular clamp was used to occlude the com-
mon bile duct at the conﬂuence of hepatic ducts to prevent
a backﬂow of injected drugs into the liver. After connecting
the epidural catheter end with the transfusion converter,
3.5% sodium taurocholate (0.1mL/100g) was transfused at
a ﬂow rate of 0.2mL/min using a microinjection pump
(produced by Zhejiang University, China). After completing
the transfusion, microvascular forceps and epidural catheter
were maintained for further 4 minutes and then removed.
A check-up was then conducted to see whether bile leakage
was present. After suturing the hole in the lateral wall of the
duodenum, the abdominal cavity was closed conventionally.
Sham-operated groups were performed just by moving the
pancreas and duodenum after opening the abdominal cavity.
Fifteen minutes after successful operation, a single dose
of Salvia miltiorrhizae injection (0.4mL/100g body weight
[24–27]) was given via femoral vein to rats in treated
groups while equal volume of physiological saline solution
was used in the sham-operated and the model control
group. Continuous infusion of physiological saline solution
using a microinjection pump was then maintained until the
end of the 3-, 6-, and 12-hour observation period in the
corresponding groups.
2.2.3. Preparation of OJ Models and Associated Thera-
peutic Regimens. After rats were anesthetized with an
intraperitoneal injection of 2.5% sodium pentobarbital
(0.2mL/100g), the abdominal cavity was opened to identify
and dissociate common bile duct along the hepatoduodenal
ligament. For rats in model control groups and the treated
groups, the proximal end of common bile duct was double-
ligated with surgical threads, common bile duct was cut oﬀ,
and a layered suture of the abdominal wall was performed
to close the abdominal cavity. For rats in sham-operated
groups, common bile duct was only dissociated but not
ligated, and a layered suture of the abdominal wall was also
performed to close the abdominal cavity. An intraperitoneal
injection of Salvia miltiorrhizae injection at a dose of
0.2mL/100g/d [24–27] was given to rats in treated groups
while equal volume of physiological saline solution was
used in the sham-operated groups and the model control
groups. Injection was maintained until the end of the 7,
14, 21, and 28-day observation period in the corresponding
groups.Mediators of Inﬂammation 3
2.3. Detecting Indexes. (1) At various time points after
operation, the mortality rate of rats was recorded. At the
corresponding time points after operation, SAP or OJ rats
wereanesthetizedwith2.5%sodiumpentobarbitalandkilled
to take blood samples and tissue specimens of spleen and
thymus that were subsequently subjected to pathological
examination and morphological observation under a light
microscope. At 12 hours after operation in SAP experiment,
the ultrastructural changes in the spleen and thymus were
also observed under an electron microscope. The patholog-
ical severity score of spleen and thymus in SAP groups and
spleen in OJ groups were analyzed, respectively.
(2) Determination of the contents of plasma endotoxin
and serum PLA2, the determination of blood parameters was
conducted according to the instructions provided with the
kits.
(3) Tissue microarray technology was used to prepare
pathological sections of spleen and thymus, and then con-
ducted immunohistochemical staining of Bax protein and
TUNEL staining. The changes in the expression levels of Bax
and the apoptosis index of lymphocyte in the spleen and
thymus were observed. Firstly, tissue microarrays sections
of spleen and thymus were prepared, the diameter was
1.5mm. The Envision two-step method was used to detect
the expression levels of Bax, a protein in the spleen and
thymus. The evaluation standard were as follows: (1) the
staining intensity was evaluated according to the extent
of cell coloration: “−” represents negative staining; “+”
representsmildstaining,positivelystainedcellsshowedayel-
low pigment; “++” represents moderate staining, positively
stained cells showed a brown pigment; “+++” represents
intensestaining, positively stained cellsshowed adark brown
pigment, each of which was scored as 0, 1, 2, and 3 points,
respectively, during statistical analysis; (2) the evaluation
standard of the positive rate: none of positive cells (−);
the percentage of positive cells was less than 25% (+); the
percentage of positive cells ranged between 26% and 50%
(++); the percentage of positive cells was more than 50%
(+++), each of which was scored as 0, 1, 2, and 3 points,
respectively, during statistical analysis. Then, DNA nick in
situ end-labeling (TUNEL) staining in tissue microarrays
sections of spleen and thymus were conducted according to
the instructions provided with the kits. The apoptotic index
was calculated. Apoptotic index= apoptotic cell count/total
cell count × 100%.
(4) The results were subjected to statistical analysis.
2.4. Statistical Analysis. The compiled data were ﬁrst input
into an Excel sheet, and then read into SPSS15.0 for further
analysis. Normal data were expressed as means (standard
deviation) while nonnormal data were expressed as medians
(interquartile range). Analysis of variance and pairwise
comparisons were used for normal data, whereas nonnormal
data were subjected to nonparametric test, among which
Kruskal-Wallis H test was used for pairwise comparisons
and Mann-Whitney U test for multiple comparisons. Yates’
chi-square test (χ2) was used for intergroup comparisons of
mortality rates.
3. Results
3.1. SAP-Associated Experiments
3.1.1. Comparison of Mortality Rate. One and ﬁve rats died
in model control groups at 3 and 12 hours after operation,
respectively; three died in treated group at 12 hours after
operation; no rats died in the remaining groups. There was
no marked diﬀerence in mortality rate between the time
points at 3 and 6 hours after operation. At 12 hours after
operation, only the mortality rate in model control group
was signiﬁcantly higher than that in sham-operated group
(P = .037), and no marked diﬀerence in mortality rate was
observed among other groups (P>. 05) [24].
3.1.2. Comparison of the Content of Endotoxin in Plasma.
At all time points after operation, the contents of plasma
endotoxin in model control group were signiﬁcantly higher
than those in sham-operated group (P<. 001). At 3 and
12 hours after operation, the contents in treated group were
signiﬁcantly higher than those in sham-operated group (P<
.01). At 6 and 12 hours after operation, the contents in
treated group were signiﬁcantly lower than those in model
control group (P<. 01), see Table 1.
3.1.3. Comparison of the Content of PLA2 in Serum. At all
time points after operation, the contents of serum PLA2 in
model control group and treated group were signiﬁcantly
higher than those in sham-operated group (P<. 001). At
6 and 12 hours after operation, the contents in treated group
were signiﬁcantly lower than those in model control group
(P<. 01), see Table 1.
3.1.4. Gross Pathological Changes and Pathological Changes
under Light and Electron Microscopy of Spleen.
(1) Sham-Operated Group.
(i) Gross Pathological Changes. At all time points after
operation, the morphology and structure of spleen
were normal in each group.
(ii) Pathological Changes under Light Microscopy. No
marked diﬀerence in pathological changes was
observed among each time point after operation.
The spleen was normal in the majority of rats. The
expansion of the blood sinuses in the red pulp of
spleen as well as focal necrosis or spotty necrosis of
the follicular germinal centers were seen in few rats.
(iii) Pathological Changes under Electron Microscopy. The
structure of lymphocytes was normal, and a great
number of red blood cells were present in the spleen
tissue.
(2) Model Control Group.
(i) Gross Pathological Changes. At 3 hours after opera-
tion, spleen congestion was seen in few rats. At 6
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Table 1: Comparison of endotoxin and PLA2 level of SAP groups (M(QR)).
Index Time Sham-operated group Model control group Treated group
Endotoxin(EU/mL)
3 hours 0.3 (0.5) 0.5(0.1)
∗∗ 0.4(0.1)
∗
6 hours 0.3 (0.2) 0.5(0.2)
∗∗ 0.4(0.1)
++
12 hours 0.3 (0.1) 0.6(0.1)
∗∗ 0.4(0.1)
∗++
PLA2 (U/mL)
3 hours 31.5 (10.1) 97.0(33.4)
∗∗ 95.1(22.9)
∗∗
6 hours 40.4 (12.1) 117.7(35.3)
∗∗ 87.2(24.9)
∗∗+
12 hours 46.0 (12.7) 126.3(15.7)
∗∗ 87.5(27.8)
∗∗+
Note: Compare to sham-operated group, ∗P <. 01, ∗∗P <. 001; compare to model control group, +P <. 01, ++P <. 001.
aggravated and the number of rats showing spleen
congestion increased; purple black plaques were seen
in some areas of spleen in some rats.
(ii) Pathological Changes under Light Microscopy. No
marked diﬀerence in pathological changes was
observed among each time point after operation. The
necrosis of the follicular centers and the expansion
of the blood sinuses in the red pulp of spleen, some
of which were accompanied by splenic arteriolar
sclerosis were seen, see Figure 1.
(iii) Pathological Changes under Electron Microscopy. The
congestion of spleen and the apoptosis of lympho-
cytes were seen.
(3) Treated Group.
(i) Gross Pathological Changes. The congestion of spleen
was mitigated. The number of rats showing spleen
congestion and purple black plaques decreased.
(ii) Pathological Changes under Light Microscopy. The
pathological changes were slightly mitigated with the
increase in therapeutic duration. At 3 hours after
operation, the structure of the white pulp and red
pulp was clear in the majority of rats; the necrosis
of the follicular germinal centers and the expansion
of the blood sinuses in the red pulp of spleen, some
of which were accompanied by splenic arteriolar
sclerosis, were seen in few rats. At 6 and 12 hours
after operation, the structure of the white pulp and
red pulp was clear and showed no abnormality in the
majority of rats; the necrosis of the follicular centers
andtheexpansionofthebloodsinusesintheredpulp
of spleen were seen in very few rats. see Figure 2.
(4) Pathological Changes under Electron Microscopy. Spleen
congestion and mitochondrial vacuolation were seen.
3.1.5. Comparison of the Pathological Severity Scores of Spleen.
Because no severity score standard for pathological changes
of spleen were reported in literature, we established the
standard according to the extent of pathological damage
of spleen, which were shown in Table 2. At all time points
after operation, the pathological severity scores of spleen in
model control group were signiﬁcantly higher than those
in sham-operated group (P<. 05). At all time points after
Figure 1: Model control group—6 hours in SAP experiment spleen
(several apoptoic cells), TUNEL × 400.
Figure 2: Treated group—6 hours in SAP experiment spleen
(several apoptoic cells) TUNEL, × 400.
Table 2: Pathological severity score standard of spleen.
Score Observation indexes
0p o i n t Normal
1p o i n t Necrosis of follicle center
2p o i n t s blood sinus dilation or arteriolar sclerosis
3p o i n t s Necrosis of follicle center, blood sinus
dilation and arteriolar sclerosis
operation, no marked diﬀerence was noted between treated
groupandsham-operatedgroup(P>. 05).At6and12hours
after operation, the scores in treated group were signiﬁcantly
lower than those in model control group (P<. 05), see
Table 3.Mediators of Inﬂammation 5
Table 3: Comparision of pathological severity score of spleen and thymus in SAP group (M(QR)).
Index Time Sham-operated group Model control group Treated group
Spleen
3 hours 0.0 (1.0) 1.0 (1.0) 0.0 (1.0)
6 hours 0.0 (0.0) 1.0 (1.0) 0.0 (1.0)
12 hours 0.0 (0.0) 1.0 (1.0) 0.0 (1.0)
Thymus
3 hours 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
6 hours 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
12 hours 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
Note: Compare to sham-operated group, ∗P <. 01, ∗∗P <. 001; compare to model control group, +P <. 01, ++P <. 001.
3.1.6. Examination of Pathological Changes of Spleen.
(1) Comparison of the Staining Intensity of Bax Protein of
Spleen. At 12 hours after operation, the staining intensity of
Bax protein of spleen in model control group was signiﬁ-
cantly higher than that in sham-operated group (P<. 01).
At all time points after operation, no signiﬁcant diﬀerence
was noted between sham-operated group and treated group
as well as between model control group and treated group
(P>. 05), see Table 4.
(2) Comparison of the Product of the Staining Intensity and
Positive Rate of Bax Protein of Spleen. At 12 hours after
operation, the product of the staining intensity and positive
rate of Bax protein of spleen in model control group was
signiﬁcantly higher than that in sham-operated group (P<
.01). At 3 hours after operation, the product in treated
group was signiﬁcantly higher than that in sham-operated
group (P<. 01). At all time points after operation, no
signiﬁcant diﬀerence was noted between treated group and
model control group (P>. 05), see Table 4.
(3) The Expression of NF-κB Protein of Spleen. The expres-
sion of NF-κB protein of spleen was negative.
(4) Comparison of the Apoptosis Index of Spleen. At all
time points after operation, no signiﬁcant diﬀerence in the
apoptosis index of spleen was noted between sham-operated
group and model control group, between sham-operated
g r o u pa n dt r e a t e dg r o u p ,a sw e l la sb e t w e e nm o d e lc o n t r o l
g r o u pa n dt r e a t e dg r o u p( P>. 05), see Table 4.
3.1.7. Gross Pathological Changes and Pathological Changes
under Light or Electron Microscopy of Thymus.
(1) Sham-Operated Group.
(i) Gross Pathological Changes. The morphology of thy-
mus was normal.
(ii) Pathological Changes under Light Microscopy. No
signiﬁcant diﬀerence in pathological changes was
noted among each time point after operation. The
thymic tissue was roughly normal in the majority of
rats. Obscure boundary between thymic cortex and
medulla was occasionally seen.
(iii) Pathological Changes under Electron Microscopy. The
structure of thymus was normal, see Figure 3.
(2) Model Control Group.
(i) Gross Pathological Changes. The morphology of thy-
mus was roughly normal.
(ii) Pathological Changes under Light Microscopy.N o
signiﬁcant diﬀerence in pathological changes was
noted among each time point after operation. The
thymic tissue was roughly normal in the majority of
rats. Obscure boundary between thymic cortex and
medulla was occasionally seen. Hemorrhage was seen
in cortico-medullary junction region.
(iii) Pathological Changes under Electron Microscopy.
Thymic cells shrank. The relative distance between
cellswaswidened.Manyapoptoticcellswereseen,see
Figure 4.
(3) Treated Group.
(i) Gross Pathological Changes. The morphology of thy-
mus was roughly normal.
(ii) Pathological Changes under Light Microscopy. No
signiﬁcant diﬀerence in pathological changes was
noted among each time point after operation. The
thymic tissue was roughly normal in the majority of
rats. Obscure boundary between thymic cortex and
medulla was occasionally seen.
(iii) Pathological Changes under Electron Microscopy. The
structure of thymus was roughly normal, see
Figure 5.
3.1.8. Comparison of the Pathological Severity Scores of Thy-
mus. The severity score of pathological changes of thymus
was conducted according to the standard reported in liter-
ature [28]. At all time points after operation, no signiﬁcant
diﬀerence in pathological severity scores was noted between
sham-operated group and model control group as well as
between sham-operated group and treated group (P>. 05).
At 3 and 6 hours after operation, the pathological severity
scores in treated group were signiﬁcantly lower than those in
model control group (P<. 05), see Table 3.6 Mediators of Inﬂammation
Table 4: Comparison of pathological indexes of spleen of SAP groups (M(QR)).
Index Time Sham-operated group Model control group Treated group
Staining intensity of Bax
3 hours 0.0 (1.0) 1.0 (2.0) 1.0 (1.5)
6 hours 0.5 (1.0) 1.0 (0.5) 1.0 (1.5)
12 hours 0.0 (1.0) 2.0(1.0)
∗ 1.0 (1.0)
P r o d u c to ft h es t a i n i n g
Intensity and positive rate
of Bax protein
3 hours 0.0 (1.5) 2.0 (2.0) 2.0(3.5)
∗
6 hours 1.0 (3.0) 2.0 (1.5) 2.0 (3.0)
12 hours 0.0 (2.0) 4.0(5.0)
∗ 2.0 (3.0)
Apoptotic indexes
3 hours 0.0 (0.0) 0.0 (0.04) 0.0 (0.01)
6 hours 0.0 (0.0) 0.0 (0.03) 0.0 (0.0)
12 hours 0.0 (0.0) 0.0 (0.08) 0.0 (0.0)
Note: Compare to sham-operated group, ∗P <. 01, ∗∗P <. 001; compare to model control group, +P <. 01, ++P <. 001.
Figure 3: Sham-operated group—12 hours in SAP experiment
thymus (normal), Electron microscope × 2550.
Figure 4: Model control group—12 hours in SAP experiment
thymus (apoptoic cells obviously increase in thymus), Electron
microscope × 1850.
Figure 5: Treated group—12 hours in SAP experiment thymus
(normal thymic lymphocyte and reticulate epithelium) Electron
microscope × 5000.
3.1.9. The Expression of Bax and NF-κB Proteins of Thymus.
The expression of Bax and NF-κB proteins of spleen was
negative.
3.2. OJ-Associated Experiments
3.2.1. Comparison of Mortality Rate. It was noted that 2, 4,
4, and 7 rats died in model control groups on 7, 14, 21, and
28days after operation, respectively; and 3, 2, and 4 rats died
in treated groups on 14, 21, and 28days after operation. The
mortality rates on 7days after operation showed no marked
diﬀerence among three experimental groups. On 14 and
21days after operation, the mortality rates in sham-operated
groups were signiﬁcantly lower than those in model control
groups (P = .032). On 28d after operation, the mortality
rate in sham-operated group was lower than those in both
the model control group (P = .006) and the treated group
(P = .032), and the diﬀerence was statistically signiﬁcant.
3.2.2. Comparison of the Content of Endotoxin in Plasma.
At all time points after operation, the contents of plasma
endotoxin in sham-operated group were signiﬁcantly lower
than those in model control group and the treated group
(P<. 01), see Table 5.
3.2.3. Comparison of the Content of PLA2 in Serum. On 14,
21, and 28days after operation, the contents of serum PLA2
in sham-operated group were signiﬁcantly lower than those
in model control group and treated group (P<. 01). On
28days after operation, the content in treated group was
signiﬁcantly lower than that in model control group (P<
.01), see Table 5.
3.2.4. Gross Pathological Changes and Pathological Changes
under Light Microscopy of Spleen.
(1) Sham-Operated Group.
(i) Gross Pathological Changes. The morphology of
spleen was normal, and no obvious pathological
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Table 5: Comparison of endotoxin and PLA2 level of OJ groups (M(QR)).
Index Time Sham-operated group Model control group Treated group
Endotoxin(EU/mL)
7days 0.2 (0.3) 0.5(0.1)
∗ 0.3(0.1)
∗+
14days 0.2 (0.4) 0.6(0.1)
∗ 0.5(0.1)
∗+
21days 0.2 (0.05) 0.7(0.1)
∗ 0.5(0.1)
∗+
28days 0.3 (0.04) 0.8(0.1)
∗ 0.5(0.1)
∗+
PLA2(U/mL)
7days 208.1 (26.6) 570.3 (239.6) 514.4 (104.3)
14days 198.5 (46.3) 653.5(208.9)
∗ 577.7(129.5)
∗
21days 207.2 (38.6) 701.0(151.7)
∗ 593.2(146.3)
∗
28days 203.0 (31.0) 738.6(60.2)
∗ 645.6(95.1)
∗+
Note: Compare to sham-operated group, ∗P <. 01, ∗∗P <. 001; compare to model control group, +P <. 01, ++P <. 001.
(ii) Pathological Changes under Light Microscopy. The
spleen was roughly normal in all rats.
(2) Model Control Group.
(i) GrossPathologicalChanges.On7daysafteroperation,
the size of spleen increased by 1.2–1.5 times, the
texture of spleen became fragile, and the color of
spleenshowednochange.On14daysafteroperation,
the spleen became enormous, with a thickness of
above 0.6cm in most parts; the color of spleen
became deeper, and the texture of spleen became
fragile. On 21 and 28days after operation, the spleen
became enormous, with an average size of 4 × 1 ×
1cm; the texture of spleen became fragile, and the
color of spleen became purple black.
(ii) Pathological Changes under Light Microscopy. On
7days after operation, the spleen was roughly normal
in all rats. On 14days after operation, the fusion,
enlargement, or spotty necrosis of follicular germinal
centers in the white pulp of spleen, the hyperplasia
of the ﬁbrous tissue in the sinus, as well as splenic
arteriolar sclerosis were seen in the majority of rats;
the spleen was roughly normal in few rats. On 21
and 28days after operation, the fusion, enlargement,
or spotty necrosis of follicular germinal centers in
the white pulp of spleen, the hyperplasia of the
ﬁbrous tissue in the sinus, as well as splenic arteriolar
sclerosis were seen in few rats; the spleen was roughly
normal in some rats, see Figure 6.
(3) Treated Group.
(i) Gross Pathological Changes. On 7 and 14days after
operation, no marked diﬀerence was observed when
compared with those in model control group. On
21 and 28days after operation, the size of spleen
increased, with an average size of 3 × 1 × 0.5cm.
(ii) Pathological Changes under Light Microscopy. No
signiﬁcant diﬀerence in pathological changes was
noted among each time point after operation. The
spleen was roughly normal in the majority of rats.
Splenic arteriolar sclerosis was seen in few rats, see
Figure 7.
Figure 6: Model control group—28days in OJ experiment spleen
(several apoptoic cells), TUNEL × 400.
Figure 7: Treated group—28days in OJ experiment spleen (several
apoptoic cells), TUNEL × 400.
3.2.5. Comparison of the Pathological Severity Scores of Spleen.
The severity score standard for pathological changes of
spleen was cited in Table 2. On 21days after operation,
the pathological severity score of spleen in model control
group was signiﬁcantly higher than that in sham-operated
group (P<. 05). At all time points after operation, no
marked diﬀerence was noted between treated group and
sham-operated group (P>. 05). On 21 and 28days after
operation, the pathological severity scores in treated group
were signiﬁcantly lower than those in model control group
(P<. 05), see Table 6.8 Mediators of Inﬂammation
3.2.6. Examination of Pathological Changes of Spleen
(1) Comparison of the Staining Intensity of Bax Protein of
Spleen. On 7, 14, and 21days after operation, the staining
intensity of Bax protein of spleen in model control group
was signiﬁcantly higher than that in sham-operated group
(P<. 01). On 7days after operation, the staining intensity
in treated group was signiﬁcantly higher than that in sham-
operated group (P<. 01). On 21days after operation, the
staining intensity in model control group was signiﬁcantly
higher than that in treated group (P<. 01), see Table 7 and
Figures 8 and 9.
(2) Comparison of the Product of the Staining Intensity and
Positive Rate of Bax Protein of Spleen. On 7, 14, and 21days
after operation, the products of the staining intensity and the
positive rate of Bax protein of spleen in model control group
were signiﬁcantly higher than those in sham-operated group
(P<. 01). On 7days after operation, the product in treated
group was signiﬁcantly higher than that in sham-operated
group (P<. 01). On 21days after operation, the product
in model control group was signiﬁcantly higher than that in
treated group (P<. 01), see Table 7.
(3) Comparison of the Staining Intensity of NF-κBo fS p l e e n .
At all time points after operation, no signiﬁcant diﬀerence in
the staining intensity of NF-κB of spleen was noted between
sham-operated group and model control group, between
s h a m - o p e r a t e dg r o u pa n dt r e a t e dg r o u p ,a sw e l la sb e t w e e n
modelcontrolgroupandtreatedgroup(P>. 05),seeTable 7.
(4) Comparison of the Product of the Staining Intensity and
thePositiveRateofNF-κBProteinofSpleen. Atalltimepoints
afteroperation,nosigniﬁcantdiﬀerenceintheproductofthe
staining intensity and the positive rate of NF-κBp r o t e i no f
spleen was noted between sham-operated group and model
control group, between sham-operated group and treated
group, as well as between model control group and treated
group (P>. 05), see Table 7.
(5) Comparison of the Apoptosis Index of Spleen. On 7, 14,
and 28days after operation, the apoptosis indexes of spleen
in model control group were signiﬁcantly higher than those
in sham-operated group (P<. 01). At all time points
after operation, no signiﬁcant diﬀerence was noted between
treated group and sham-operated group (P>. 05). On
28days after operation, the apoptosis index in treated group
was signiﬁcantly lower than that in model control group
(P<. 01), see Table 7.
3.2.7. Gross Pathological Changes and Pathological Changes
under Light Microscopy of Thymus.
(1) Sham-Operated Group.
(i) Pathological Changes under Light Microscopy. No
signiﬁcant diﬀerence in pathological changes was
noted among each time point after operation. The
Figure 8: Model control group—21d in OJ experiment (++)
spleen, Bax × 200.
Figure 9: Treated group—21d in OJ experiment (+) spleen, Bax ×
200.
thymic tissue was roughly normal in all rats, see
Figure 10.
(2) Model Control Group.
(i) GrossPathologicalChanges.On7daysafteroperation,
the thymus slightly shrank in the majority of rats.
On 14days after operation, the thymus shrank and
became jaundice in the majority of rats. On 21
and 28days after operation, the thymus signiﬁcantly
shrank and became jaundice in all rats.
(ii) Pathological Changes under Light Microscopy.N o
signiﬁcant diﬀerence in pathological changes was
noted among each time point after operation. The
thymic tissue was roughly normal in the majority
of rats. Obscure boundary between thymic cortex
and medulla was occasionally seen. On 14days after
operation,thethymictissuewasroughlynormal.The
pathological changes were similar among 14, 21, and
28days afteroperation: the thymic tissue wasroughly
normalinthemajorityofrats,andobscureboundary
between thymic cortex and medulla was occasionally
seen, see Figure 11.
(3) Treated Group.
(i) Gross Pathological Changes. On 7 and 14days after
operation, no marked diﬀerence was observed when
compared with those in model control group. On
21 and 28days after operation, the thymus became
slightly jaundice but showed no obvious shrinkage.Mediators of Inﬂammation 9
Table 6: Comparision of pathological severity score of spleen in OJ group (M(QR)).
Index Time Sham-operated group Model control group Treated group
Pathological severity score of spleen
7days 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
14days 0.0 (1.0) 0.0 (2.0) 0.0 (0.0)
21days 0.0 (0.0) 1.0 (2.0) 0.0 (0.0)
28days 0.0 (0.0) 0.0 (1.0) 0.0 (0.0)
Note: Compare to sham-operated group, ∗P <. 01, ∗∗P <. 001; compare to model control group, +P <. 01, ++P <. 001.
Table 7: Comparison of pathological indexes of spleen in OJ groups (M(QR)).
Index Time Sham-operated group Model control group Treated group
Staining intensity of Bax 7days 0.0 (2.0) 2.0( 0 .0)
∗ 2.0( 1 .0)
∗
14days 2.0 (2.0) 2.0( 1 .0)
∗ 2.0 (0.0)
21days 1.0 (2.0) 3.0( 1 .0)
∗ 2.0( 1 .0)
+
28days 1.0(2.0) 1.0 (2.0) 0.0 (2.0)
Product of staining
intensity and positive rate
of Bax
7days 0.0 (2.0) 4.0(2.0)
∗ 2.0(3.0)
∗
14days 2.0 (4.0) 4.0( 2 .0)
∗ 4.0 (2.0)
21days 2.0 (4.0) 6.0( 2 .0)
∗ 4.0( 3 .0)
+
28days 1.0 (4.0) 0.5 (1.5) 0.0 (2.0)
Apoptotic indexes 7days 0.0 (0.0) 0.0(0.01)
∗ 0.0 (0.0)
14days 0.0 (0.0) 0.0( 0 .01)
∗ 0.0 (0.0)
21days 0.0 (0.0) 0.0 (0.002) 0.0 (0.0)
28days 0.0 (0.0) 0.002 (0.015)
∗ 0.0(0.0)
+
Staining intensity of NF-κB 7days 0.0 (0.0) 0.0 (1.0) 0.0 (0.0)
14days 0.0 (1.0) 0.0 (1.0) 0.0 (0.5)
21days 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
28days 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
Product of staining
intensity and positive rate
of NF-κB
7days 0.0 (0.0) 0.0 (1.0) 0.0 (0.0)
14days 0.0 (1.0) 0.0 (2.0) 0.0 (0.5)
21days 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
28days 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
Note: Compare to sham-operated group, ∗P <. 01, ∗∗P <. 001; compare to model control group, +P <. 01, ++P <. 001.
(ii) Pathological Changes under Light Microscopy. No sig-
niﬁcant diﬀerence in pathological changes was noted
among each time point after operation. The thymic
tissue was normal. Obscure boundary between
thymic cortex and medulla was occasionally seen.
On 7, 21, and 28days after operation, the thymic
tissue was roughly normal in the majority of rats,
and obscure boundary between thymic cortex and
medulla of was seen in some rats. On 14days after
operation, the thymic tissue was roughly normal, see
Figure 12.
3.2.8. Examination of Pathological Changes of Thymus.
(1) Comparison of the Staining Intensity of Bax Protein of
Thymus. On 7, 21, and 28days after operation, the staining
intensity of Bax protein of thymus in model control group
was signiﬁcantly higher than that in sham-operated group
(P<. 01). At all time points after operation, no signiﬁcant
diﬀerence was noted between treated group and sham-
operated group as well as between treated group and model
control group (P>. 05), see Table 8 and Figures 13 and 14.
(2) Comparison of the Product of the Staining Intensity and
the Positive Rate of Bax Protein of Thymus. On 7, 21, and 28
days after operation, the products of the staining intensity
and the positive rate of Bax protein of thymus in model
control group were signiﬁcantly higher than those in sham-
operated group (P<. 01). At all time points after operation,
no signiﬁcant diﬀerence was noted between treated group
and sham-operated group as well as between treated group
and model control group (P>. 05), see Table 8.10 Mediators of Inﬂammation
Table 8: Comparison of pathological indexes of thymus in OJ groups (M(QR)).
Index Time Sham-operated group Model control group Treated group
Staining intensity of Bax
7days 0.0 (0.0) 1.0( 1 .0)
∗ 0.0 (1.0)
14days 0.0 (1.0) 1.0 (1.0) 0.0 (1.0)
21days 0.0 (0.0) 1.0( 1 .0)
∗ 0.0 (1.0)
28days 0.0 (0.0) 1.0( 1 .0)
∗ 0.0 (1.0)
Product of staining
intensity and positive rate
of Bax
7days 0.0 (0.0) 0.0(0.0)
∗ 0.0 (1.0)
14days 0.0 (1.0) 0.0 (1.0) 0.0 (1.0)
21days 0.0 (0.0) 0.0( 0 .0)
∗ 0.0 (1.0)
28days 0.0 (0.0) 2.0( 1 .5)
∗ 0.0 (1.0)
Apoptotic indexes
7days 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
14days 0.0 (0.0) 0.0 (0.01) 0.0 (0.0)
21days 0.0 (0.0) 0.0( 0 .01)
∗ 0.0 (0.0)
28days 0.0 (0.0) 0.0( 0 .02)
∗ 0.0 (0.0)
Staining intensity of NF-κB
7days 0.0 (0.0) 0.0 (2.0) 0.0 (1.0)
14days 0.0 (2.0) 1.0 (2.0) 0.0 (1.5)
21days 0.0 (1.0) 0.0 (1.0) 0.0 (0.0)
28days 0.0 (1.0) 0.0 (1.5) 0.0 (2.0)
Product of staining
intensity and positive rate
of NF-κB
7days 0.0 (0.0) 0.0 (2.0) 0.0 (2.0)
14days 0.0 (4.0) 2.0 (4.0) 0.0 (2.0)
21days 0.0 (2.0) 0.0 (2.0) 0.0 (0.0)
28days 0.0 (1.0) 0.0 (2.5) 0.0 (4.0)
Note: Compare to sham-operated group, ∗P <. 01, ∗∗P <. 001; compare to model control group, +P <. 01, ++P <. 001.
Figure 10: Sham-operated group—28d in OJ experiment thymus
(negative TUNEL × 200).
(3) Comparison of the Staining Intensity of NF-κB of Thymus.
At all time points after operation, no signiﬁcant diﬀerence
in the staining intensity of NF-κBo ft h y m u sw a sn o t e d
between sham-operated group and model control group,
between sham-operated group and treated group, as well as
between model control group and treated group (P>. 05).
See Table 8.
(4) Comparisonof the Product of the Staining Intensity and the
Positive Rate of NF-κB Protein of Thymus. At all time points
afteroperation,nosigniﬁcantdiﬀerenceintheproductofthe
staining intensity and the positive rate of NF-κBp r o t e i no f
thymus was noted between sham-operated group and model
control group, between sham-operated group and treated
group, as well as between model control group and treated
group (P>. 05), see Table 8 .
Figure 11: Model control group—28d in OJ experiment thymus
(many apoptoic cells), TUNEL × 400.
(5) Comparison of the Apoptosis Index of Thymus. On 21 and
28days after operation, the apoptosis indexes of thymus in
model control group were signiﬁcantly higher than those
in sham-operated group (P<. 01). At all time points
after operation, no signiﬁcant diﬀerence was noted between
treated group and sham-operated group as well as between
treatedgroupandmodelcontrolgroup(P>. 05),seeTable 8.
4. Discussion
At present, the immune organ injury in SAP and OJ has
attracted more and more attention. An indispensable step toMediators of Inﬂammation 11
Figure 12: Treated group—28d in OJ experiment thymus (several
apoptoic cells), TUNEL × 400.
Figure 13: Model control group—7d in OJ experiment thymus
(+++), Bax × 200.
treat SAP and OJ is to help restore the function of the body’s
immune organs using drugs. SAP and OJ, as are diseases
commonly seen in the departments of general surgery and
digestive medicine, are sensitive, to a certain extent, to
auxiliary treatment with Chinese traditional drugs. Salvia
miltiorrhizae injection, an extract from Chinese traditional
drug Salvia miltiorrhizae, possesses the vast majority of
pharmacological eﬀects of Salvia miltiorrhizae. Clinically,
salvia miltiorrhizae injection is mainly used to promote
blood ﬂow and remove blood stasis. Some studies have
proven that the tanshinol contained in Salvia miltiorrhizae
canexerttherapeuticeﬀectsonSAPandOJthroughavariety
of pharmacological actions [17–20].
When SAP develops, gut-derived endotoxins enter into
the systemic circulation and cause intestinal endotoxemia
which can increase the permeability of intestinal mucosa and
facilitate the invasion of intestinal bacteria and endotoxins
into the body. Thus, a vicious cycle is formed [29]. As a
result, the activated monocytes and macrophages are further
stimulated to release excessive cytokines and inﬂammatory
mediators that can form a cascade reaction to amplify the
initial signal. Ultimately, SIRS and MODS are caused [30].
Clinical studies [31, 32] prove that an insuﬃciency of bile
salts in the intestine can cause excessive multiplication of
intestinal bacteria, which can induce an increase in the
production but a decrease in the activation of endotoxins.
Moreover, the function of the reticuloendothelial system is
inhibited. Thus, gut-derived endotoxins cannot be eﬀectively
removed and, as a consequence, enter into the blood to
Figure 14: Model control group—21d in OJ experiment thymus
(++), Bax × 200.
cause endotoxemia. The immune function injury in OJ
patients is mainly contributed to endotoxin-induced damage
to humoral and cellular immune responses [33].
We think that the lower systemic immune function
in OJ patients creates conditions for the occurrence of
endotoxemia which can in turn induce the damage to
the body’s immune function. We speculate that immune
function injury results from the damage to immune organs.
Comparing the pathological changes of spleen and thymus,
we found that varying degrees of pathological damage were
present in the spleen and thymus of SAP rats and the spleen
of OJ rats in model control group but pathological damage
in the thymus of OJ rats was slight. After treatment with
Salvia miltiorrhizae, the pathological changes of spleen and
thymus were mitigated, suggesting that Salvia miltiorrhizae
is able to improve the pathological damage present in the
spleen and thymus of SAP rats and the spleen of OJ rats.
Additionally, the mortality rates of SAP and OJ rats in model
control group were almost two times as high as those in
Treated group, suggesting that Salvia miltiorrhizae injection
can indeed reduce the mortality rate of rats. However, no
statistically signiﬁcant diﬀerence was observed because the
sample size was too small.
The results of this study showed that the contents of
plasma endotoxin in SAP and OJ rats in model control
group were signiﬁcantly higher than those in sham-operated
group, indicating that SAP and OJ can increase the contents
of plasma endotoxin in rats. We believe that SAP and OJ
can lead to an increase in the contents of endotoxin not
only through causing intestinal mucosal barrier dysfunction,
invasion of intestinal ﬂora into blood, and the dissolving
b a c t e r i a lc e l lw a l l[ 34] but also through inducing hepatic
injuryandthedeclineinthephagocyticclearancefunctionof
Kupﬀer cells [35]. After treatment with Salvia miltiorrhizae,
the contents of plasma endotoxin in SAP and OJ rats
in treated group were signiﬁcantly lower than those in
model control group, indicating that Salvia miltiorrhizae
can eﬀectively decrease the levels of plasma endotoxin. We
think that this eﬀect may be associated with hepatic injury
and intestinal mucosal barrier dysfunction in SAP or OJ,
which has been proved in our previous studies (to be
reported in other papers). On one hand, Salvia miltiorrhizae
h a sp r o t e c t i v ee ﬀects on the liver since it can enhance
the phagocytic clearance function of Kupﬀer cells, decrease
the levels of inﬂammatory mediators, and scavenge free12 Mediators of Inﬂammation
radicals. On the other hand, Salvia miltiorrhizae is able to
protect intestinal mucosa barrier and inhibit the invasion
of intestinal ﬂora into blood. The synergistic action of
these two factors can eventually antagonize the eﬀects of
endotoxin.
PhospholipaseA2 (PLA2),anenzymetopotentlycatalyze
the hydrolysis of phospholipids, is closely related to the
severity of SAP [36]. The inhibitors of PLA2 can improve the
prognosis of SAP [37, 38]. In a certain range, the levels of
PLA2 can sensitively reﬂect the extent of pancreatic injury
and are therefore used as an important parameter in the
diagnosis of SAP [39]. In SAP, pancreatic lysosomes release
a large amount of PLA2. Upon activation, PLA2 can act
on spleen and thymus mitochondria and aﬀect the levels
of phosphatidylcholine (PC) and phosphatidylethanolamine
(PE), thereby altering the ultrastructure of spleen and
thymus. In OJ, due to the reduction of ATP synthesis, ATP-
dependentcalciumpumpdisordersandmembranelipidper-
oxidation damage, cytoplasmic free calcium overload occurs.
As a result, PLA2 is activated to promote the hydrolysis
of membrane phospholipid, induce cell membrane damage,
and cause the dysregulation of immune function. The results
of this study showed that the contents of PLA2 in SAP
and OJ rats in model control group were signiﬁcantly
higher than those in sham-operated groups. After treatment
with Salvia miltiorrhizae, the contents of PLA2 in treated
group were signiﬁcantly lower than those in model control
group, indicating that Salvia miltiorrhizae can eﬀectively
reduce the contents of PLA2 via a mechanism that may
be associated with inhibiting the release of PLA2 from
lysosomes.
Apoptosis is a self-protective strategy employed by the
body for removal of the destroyed cells through initiating
programmed gene expression under certain pathophysi-
ological conditions [39]. Bax is a soluble protein that
is encoded by a recently discovered apoptosis-promoting
gene. It is in the same protein family as Bcl-2 and is
able to promote apoptosis [40, 41]. Our results showed
that, at 12 hours after operation, the expression level of
Bax protein in the spleen of SAP rats in model control
group was signiﬁcantly higher than that in sham-operated
group, and the pathological damage in the former group
was aggravated though there were no obvious changes in
the apoptosis index. In contrast, at all time points after
operation, the expression levels of Bax protein in the
spleen and thymus of OJ rats in model control group were
signiﬁcantly higher than those in sham-operated group,
the pathological damage was aggravated, and the apoptosis
index increased. These results suggest that Bax protein is
involved in the pathological and physiological processes of
apoptosis present in the spleen and thymus of OJ rats. After
treatment with Salvia miltiorrhizae injection, the expression
of Bax protein in the spleen and thymus was, to varying
degrees, downregulated, the apoptosis index decreased, and
the pathological damage was improved in SAP and OJ rats.
The therapeutic eﬀects of Salvia miltiorrhizae on OJ rats
were more prominent: the expression level of Bax protein
(on 21days after operation) and the apoptosis index (on
28days after operation) of spleen in treated group were
signiﬁcantly lower than those in model control group.
However, statistical results showed that the strength of
Salvia miltiorrhizae was insuﬃcient in downregulating the
expression of Bax protein and inducing apoptosis in the
spleen and thymus of SAP and OJ rats, and no statistically
signiﬁcant diﬀerence was observed. For these reasons, we
think that Bax protein is not a key factor for inducing
apoptosis. We surmise that cell apoptosis results from
multiple contributing factors and Salvia miltiorrhizae only
plays a weak role in modulating the expression of Bax
protein and, therefore, shows no prominent eﬀect on cell
apoptosis. When SAP or OJ occurs, the apoptosis does not
result from a certain factor but from multiple contributing
factors.
NF-κBp 6 5i sap r o t e i nt h a ti sa b l et or e g u l a t eg e n e
transcription in the nucleus and is involved in the gene
regulation of multiple inﬂammatory factors [42]. When the
body is under stress, NF-κB p65 is activated and binds
to speciﬁc κB gene sequences, thereby promoting the gene
transcription and protein synthesis of proinﬂammatory
molecules, causing the strong expression of inﬂammatory
cytokines such as TNF-α and IL-6mRNA, accelerating toxic
eﬀect on cells in multiple organs, and eventually leading to
multiple organ dysfunction. In this study, we found that
the staining intensity of NF-κB p65 protein in the spleen
and thymus of SAP and OJ rats in model control group
was not signiﬁcantly higher than that in sham-operated
group. After treatment with Salvia miltiorrhizae injection,
although the intensity of NF-κB p65 protein in the spleen
and thymus of SAP and OJ rats showed varying degrees of
decline, no statistically signiﬁcant diﬀerence was observed.
Thus, we think that NF-κB p65 is not activated or only shows
weak activity in the spleen and thymus of SAP and OJ rats.
Alternatively, Salvia miltiorrhizae may have no or show weak
eﬀect on the expression of NF-κB p65 protein in the spleen
a n dt h y m u so fS A Pa n dO Jr a t s .
To sum up, Salvia miltiorrhizae injection can exert
protective eﬀects on the spleen and thymus of SAP rats
and the spleen of OJ rats through reducing the contents of
endotoxin and PLA2 in blood, improving the pathological
damage present in the spleen and thymus of SAP rats and the
spleenofOJrats,andinhibitingtheexpressionofBaxprotein
in the spleen of OJ rats and the apoptosis. Moreover, Salvia
miltiorrhizae injection is also able to increase the survival
rates of SAP and OJ rats. For these reasons, the application of
Salvia miltiorrhizae for treating SAP deserves spreading and
further in-depth study.
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